Intern - Development - Business Process at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Must be at least 18 years old
Must have a minimum GPA of 2.8
Authorized to work in the United States without sponsorship now or in the future or CPT/OPT through your University
Must be currently enrolled as a full-time student in a Bachelor’s/Masters/MBA/PhD program at an accredited US based university or college
Must be a Rising Sophomore, Junior, or Senior in undergrad or a Graduate or Doctoral Student
Must be enrolled full-time in the Fall Semester at an accredited university/college after the completion of the internship
Must be able to complete a 10-12 consecutive week internship between May and August
Must be able to relocate if necessary and work at the designated site for the duration of the internship
Preferred Qualifications
Preferred Degree qualification: Undergrad/Graduate
Proficiency with MS Office Suite
Ability to identify issues and seek solutions
Ability to work both independently and collaboratively
Demonstrated commitment to inclusion and diversity in the workplace
Efficient, organized, and able to handle short timelines in a fast-paced environment
Gilead Core Values: Integrity (Doing What’s Right), Inclusion (Encouraging Diversity), Teamwork

Responsibilities

Conduct process analysis and optimization by mapping clinical data workflows, identifying improvement opportunities, and developing prioritized recommendations with implementation roadmaps
Support quality assurance activities including QC reviews, metrics analysis, audit preparation, and development of quality tools aligned with regulatory standards (21 CFR Part 11, ICH-GCP)
Design and develop training materials by conducting needs assessments, creating training modules, quick reference guides, and assessment tools for key processes and systems
Collaborate cross-functionally with Process, Quality, and Training stakeholders to validate recommendations, support improvement implementations, and document outcomes with measurable metrics
Create professional documentation including process maps, gap analyses, quality improvement proposals, implementation summaries, and organized knowledge repositories
Deliver formal capstone presentation to senior leadership synthesizing 8-week findings, recommendations, and contributions in a 25-30 minute presentation with data visualizations and strategic insights

Skills

Process Analysis

Process Optimization

Workflow Mapping

Clinical Data

Quality Assurance

QC Reviews

Metrics Analysis

Audit Preparation

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free